Re: Sabizabulin - mCRPC- used now for Covid 19.
in response to
by
posted on
Apr 16, 2022 07:27PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
It seems to me that management has been leaning towards licencing-type partnerships with the ones Zenith is collaborating with at present and possibly more to come.
Perhaps all we need is one successful collaboration, creating a gateway to a successful Zenith IPO.
IMO ... Koo